![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway
Publisher: Spandidos Publications
E-ISSN: 1791-2431|33|1|494-502
ISSN: 1021-335X
Source: Oncology Reports, Vol.33, Iss.1, 2015-01, pp. : 494-502
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)